Scholar

Peter Rodgers

H-index: 27
Business 35%
Economics 27%

Reposted by: Peter Rodgers

richardsever.bsky.social
New accessibility pilot on bioRxiv pilot: AI-generated paper summaries at 3 levels (general -> expert).

Click Automated Services in the dashboard to view these. We welcome feedback. connect.biorxiv.org/news/2023/11...

Reposted by: Peter Rodgers

paulguinnessy.bsky.social
I remember it was quicker to set a job running on our 32-bit VAX-11 overnight, than it was to get the results back from he supercomputer up in Birmingham (because it was so oversubscribed). thechipletter.substack.com/p/why-are-th...
Why Are There No Minicomputers Any More?
What lessons can we learn from the demise of 'mini' form factor, architectures and companies?
thechipletter.substack.com

Reposted by: Peter Rodgers

elife.bsky.social
A new computational tool provides insights into the structure of the cerebellum in mammals. elifesciences.org/articles/931...

Reposted by: Peter Rodgers

steveroyle.bsky.social
Please suggest a cool paper/preprint in your field in the last year or so!
For a course I teach, I am collecting papers on: cell/dev bio, microbio, neuro, maths/stats/CS/chem/phys applied to biology.

🧪
1/2

Reposted by: Peter Rodgers

sjangtenhagen.bsky.social
CALL FOR ABSTRACTS – I'm teaming up with Marie-Gabrielle Verbergt to edit a special issue of Minerva on the history of peer review in the humanities (and its connection to the sciences). Submit your abstracts by March 15, 2024, and help us spread the word!

link.springer.com/collections/...
Call for Abstracts: The Past and Present of Humanities Peer Review
Abstract submission deadline: 15 March 2024 Peer review, i.e. the institutionalized evaluation of scholars and their outputs by others working in the same ...
link.springer.com

Reposted by: Peter Rodgers

lrb.co.uk
‘When the painting was rediscovered by modern scholars in the 1990s, many distinguished commentators presumed that it was a caricature.’

Fara Dabhoiwala on uncovering the secret of the 18th-century portrait of a Jamaican scholar and businessman:
www.lrb.co.uk/the-paper/v4...
Fara Dabhoiwala · A Man of Parts and Learning: Francis Williams Gets His Due
The only certainty about the picture is that it shows Francis Williams. No one has ever been able to discover who...
www.lrb.co.uk

Reposted by: Peter Rodgers

rorinstitute.bsky.social
The peer review system needs change. Let’s make publishing faster, more efficient, and rewarding 📈

Join us on 21 Nov at #AIMOS2024 or online on 26 Nov for the launch of MetaROR - an open platform by RoRI & AIMOS making reviews visible & reusable.

More info: researchonresearch.org/metaror-laun...

Reposted by: Peter Rodgers

Reposted by: Peter Rodgers

elife.bsky.social
🎉 eLife is pleased to announce Timothy Behrens (@behrenstimb.bsky.social) as our new Editor-in-Chief!

A distinguished neuroscientist and long-time supporter, Tim will lead our efforts in transforming research communication for all.
eLife appoints Timothy Behrens as Editor-in-Chief
Behrens will lead eLife’s efforts to improve research communication for all.
buff.ly
behrenstimb.bsky.social
Hope you'll forgive a quick thread as I take over as the new EiC of @elife.bsky.social

Reposted by: Peter Rodgers

castelvecchi.bsky.social
CERN's secular plan: Can we predict what technologies will be available 50 years from now that could make high-energy colliders radically different — or even obsolete? And some wonder whether we can even imagine what questions physicists will be asking in 2070. #FCC
www.nature.com/articles/d41...
The biggest machine in science: inside the fight to build the next giant particle collider
The European physics laboratory CERN is planning to build a mega collider by 2070. Critics say the plan could lead to its ruin.
www.nature.com

Reposted by: Peter Rodgers

annagreene.bsky.social
Last year, I was surprisingly diagnosed with AML. Attacks on science that we currently face threaten future scientific discoveries that can benefit individuals' health. This should scare us all. Read more about my story and thoughts on this below (with @casey.greenelab.com).

Reposted by: Peter Rodgers

mayankchugh.bsky.social
My undergraduate students & I have been having discussions about what the current US policies mean for the science, their career aspirations, & public health.

Thank you @drpeterrodgers.bsky.social @elife.bsky.social @elifecommunity.bsky.social
for giving us a space to share our voices & fears.

Reposted by: Peter Rodgers

elife.bsky.social
1/ NIH-funded research has come under a new level of fiscal scrutiny under Trump, sending shock waves through biomedical research.

As Nick Gilpin writes, at the core of these cuts is one question: Is it a worthwhile investment for the US taxpayer?
buff.ly/qJ8axNe
"Given the opportunity to invest one dollar and receive a guaranteed $2.56 in return, most Americans would likely do so without hesitation." Nicholas Gilpin

Reposted by: Peter Rodgers

elife.bsky.social
@abankston.bsky.social – a science policy fellow at the US House Representatives – outlines some options available for responding to the attacks on science and the scientific workforce in the US.
buff.ly/udqoZI5

Reposted by: Peter Rodgers

elife.bsky.social
There is plenty of scope for reducing bureaucracy for the benefit of research, @stuartbuck.bsky.social argues. However, Elon Musk and the Department of Government Efficiency are going about this completely the wrong way.
buff.ly/aLkxKhC
"If DOGE wants to fulfil the original mission to reduce bureaucracy and improve efficiency, it needs to execute a 180 degree change of direction." Stuart Buck
Webinar about the Brazilian Reproducibility Initiative next Friday.

And you you cannot wait until then . . . .
elifesciences.org/interviews/3...

Reposted by: Peter Rodgers

elife.bsky.social
Heading to #ASBMB25? Find us at stand 333 to talk about our publishing model and what we're doing for #OpenScience!

At the stand, you'll find friendly faces Shane Alsop and Matthew Perkins, plus some exclusive eLife goodies. We hope to see you there!
phot of shane and matthew at the E life booth at ASBMB
Congratulations to the Brazilian Reproducibility Initiative on publishing “Estimating the replicability of Brazilian biomedical science”.
Bottom line: replication rates varied between 15 and 45%
96 replications of 47 experiments were considered valid by an independent committee.

For these experiments, replication rates varied between 15 and 45% (according to 5 predefined criteria)

@elife.bsky.social article from 2019 about the initiative: elifesciences.org/articles/41602
Science Forum: The Brazilian Reproducibility Initiative
Researchers are undertaking a systematic assessment of the reproducibility of biomedical science in Brazil.
elifesciences.org

References

Fields & subjects

Updated 1m